Hsbc Holdings PLC Avid Bioservices, Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $21,827 - $32,438	1,731 Added 14.78%	13,444 $185,000
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $70,855 - $94,103	-4,622 Reduced 28.3%	11,713 $227,000
Q2 2022 Aug 11, 2022	SELL	$11.63 - $21.55 $19,643 - $36,397	-1,689 Reduced 9.37%	16,335 $249,000
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $115,262 - $192,196	6,931 Added 62.48%	18,024 $376,000
Q4 2021 Feb 11, 2022	BUY	$20.7 - $34.18 $229,625 - $379,158	11,093 New	11,093 $323,000

188

68.4M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.